# PubMed record PMID 28609423

> PeptideScanner retained PubMed bibliographic metadata for PMID 28609423 at 2026-07-30T21:09:26.729Z. PubMed recorded a metadata revision date of 2018-11-05 and an Entrez history date of 2017-06-14. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-28609423-abaloparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-11-05
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-28609423-abaloparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-28609423-abaloparatide-v1.json
- Content SHA-256: `6ceeb553160c8b0c99e2b69e2a6e3c0161f786cc520ace145451d9395a8c4865`

## Claims and source pins

### Headline

PubMed record PMID 28609423 ([`pubmed-observation-pmid-28609423-2018-11-05-df73df22ca9c`](#source-pubmed-observation-pmid-28609423-2018-11-05-df73df22ca9c))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 28609423 at 2026-07-30T21:09:26.729Z. PubMed recorded a metadata revision date of 2018-11-05 and an Entrez history date of 2017-06-14. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-28609423-2018-11-05-df73df22ca9c`](#source-pubmed-observation-pmid-28609423-2018-11-05-df73df22ca9c))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 28609423 at 2026-07-30T21:09:26.729Z. PubMed recorded a metadata revision date of 2018-11-05 and an Entrez history date of 2017-06-14. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-28609423-2018-11-05-df73df22ca9c`](#source-pubmed-observation-pmid-28609423-2018-11-05-df73df22ca9c))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-28609423-2018-11-05-df73df22ca9c`](#source-pubmed-observation-pmid-28609423-2018-11-05-df73df22ca9c))

## Sources

<a id="source-pubmed-observation-pmid-28609423-2018-11-05-df73df22ca9c"></a>
- **PubMed record PMID 28609423 · retained source version 1:2018-11-05:current:df73df22ca9c89ae082a8c3fa6acde71c259e3b1a56e4d2457a3d9d091baebe8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/28609423/) (`pubmed-observation-pmid-28609423-2018-11-05-df73df22ca9c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 28609423." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-28609423-abaloparatide-v1.json SHA-256: 6ceeb553160c8b0c99e2b69e2a6e3c0161f786cc520ace145451d9395a8c4865.